These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 34195328)

  • 21. Matching-adjusted Indirect Comparisons of the Efficacy and Safety of Acalabrutinib Versus Other Targeted Therapies in Relapsed/Refractory Mantle Cell Lymphoma.
    Telford C; Kabadi SM; Abhyankar S; Song J; Signorovitch J; Zhao J; Yao Z
    Clin Ther; 2019 Nov; 41(11):2357-2379.e1. PubMed ID: 31699438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA signature obtained from the comparison of aggressive with indolent non-Hodgkin lymphomas: potential prognostic value in mantle-cell lymphoma.
    Goswami RS; Atenafu EG; Xuan Y; Waldron L; Reis PP; Sun T; Datti A; Xu W; Kuruvilla J; Good DJ; Lai R; Church AJ; Lam WS; Baetz T; Lebrun DP; Sehn LH; Farinha P; Jurisica I; Bailey DJ; Gascoyne RD; Crump M; Kamel-Reid S
    J Clin Oncol; 2013 Aug; 31(23):2903-11. PubMed ID: 23835716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Front-line management of indolent non-Hodgkin lymphoma in Australia. Part 2: mantle cell lymphoma and marginal zone lymphoma.
    Cheah CY; Opat S; Trotman J; Marlton P
    Intern Med J; 2019 Sep; 49(9):1070-1080. PubMed ID: 30816618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclin D1-negative blastoid mantle cell lymphoma identified by SOX11 expression.
    Zeng W; Fu K; Quintanilla-Fend L; Lim M; Ondrejka S; Hsi ED
    Am J Surg Pathol; 2012 Feb; 36(2):214-9. PubMed ID: 22251940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case report of mantle cell lymphoma manifesting as a foot lesion.
    Samarghandi A; Ahuja S; Gupta S; Fulger I; Katava G; Fang Y
    Tumori; 2016 Nov; 102(Suppl. 2):. PubMed ID: 26797933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Smoldering mantle cell lymphoma.
    Ye H; Desai A; Zeng D; Nomie K; Romaguera J; Ahmed M; Wang ML
    J Exp Clin Cancer Res; 2017 Dec; 36(1):185. PubMed ID: 29246179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extranodal mantle cell lymphoma mimicking marginal zone cell lymphoma.
    Anagnostopoulos I; Foss HD; Hummel M; Trenn G; Stein H
    Histopathology; 2001 Dec; 39(6):561-5. PubMed ID: 11903572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology and etiology of mantle cell lymphoma and other non-Hodgkin lymphoma subtypes.
    Smedby KE; Hjalgrim H
    Semin Cancer Biol; 2011 Nov; 21(5):293-8. PubMed ID: 21945518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Skin Involvement of Mantle Cell Lymphoma May Mimic Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type.
    Wehkamp U; Pott C; Unterhalt M; Koch K; Weichenthal M; Klapper W; Oschlies I
    Am J Surg Pathol; 2015 Aug; 39(8):1093-101. PubMed ID: 26034867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors affecting toxicity, response and progression-free survival in relapsed patients with indolent B-cell lymphoma and mantle cell lymphoma treated with rituximab: a Japanese phase II study.
    Igarashi T; Kobayashi Y; Ogura M; Kinoshita T; Ohtsu T; Sasaki Y; Morishima Y; Murate T; Kasai M; Uike N; Taniwaki M; Kano Y; Ohnishi K; Matsuno Y; Nakamura S; Mori S; Ohashi Y; Tobinai K;
    Ann Oncol; 2002 Jun; 13(6):928-43. PubMed ID: 12123339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma.
    Foran JM; Rohatiner AZ; Cunningham D; Popescu RA; Solal-Celigny P; Ghielmini M; Coiffier B; Johnson PW; Gisselbrecht C; Reyes F; Radford JA; Bessell EM; Souleau B; Benzohra A; Lister TA
    J Clin Oncol; 2000 Jan; 18(2):317-24. PubMed ID: 10637245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mantle cell lymphoma and diffuse large B-cell lymphoma of the testis: a unique case of composite non-Hodgkin lymphoma.
    Andhavarapu S; Crozier JA; Jiang L; Sher T
    Eur J Haematol; 2014 Dec; 93(6):537-42. PubMed ID: 24750331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subclonal evolution of a classical Hodgkin lymphoma from a germinal center B-cell-derived mantle cell lymphoma.
    Schneider S; Crescenzi B; Schneider M; Ascani S; Hartmann S; Hansmann ML; Falini B; Mecucci C; Tiacci E; Küppers R
    Int J Cancer; 2014 Feb; 134(4):832-43. PubMed ID: 23929122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study.
    Palanca-Wessels MC; Czuczman M; Salles G; Assouline S; Sehn LH; Flinn I; Patel MR; Sangha R; Hagenbeek A; Advani R; Tilly H; Casasnovas O; Press OW; Yalamanchili S; Kahn R; Dere RC; Lu D; Jones S; Jones C; Chu YW; Morschhauser F
    Lancet Oncol; 2015 Jun; 16(6):704-15. PubMed ID: 25925619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rituximab in the treatment of non-Hodgkin's lymphoma--a critical evaluation of randomized controlled trials.
    Griffin MM; Morley N
    Expert Opin Biol Ther; 2013 May; 13(5):803-11. PubMed ID: 23560506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Composite Hodgkin lymphoma and mantle cell lymphoma: two clonally unrelated tumors.
    Caleo A; Sánchez-Aguilera A; Rodríguez S; Dotor AM; Beltrán L; de Larrinoa AF; Menárguez FJ; Piris MA; García JF
    Am J Surg Pathol; 2003 Dec; 27(12):1577-80. PubMed ID: 14657719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p27(Kip1) immunostaining for the differential diagnosis of small b-cell neoplasms in trephine bone marrow biopsies.
    Kremer M; Dirnhofer S; Nickl A; Hoefler H; Quintanilla-Martínez L; Fend F
    Mod Pathol; 2001 Oct; 14(10):1022-9. PubMed ID: 11598173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunotherapy in mantle cell lymphoma: anti-CD20-based therapy and beyond.
    Zhou Y; Zhang L; Romaguera J; Delasalle K; Han X; Du X; Kwak L; Yi Q; Wang M
    Am J Hematol; 2008 Feb; 83(2):144-9. PubMed ID: 17722077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simplified MIPI-B prognostic stratification method can predict the outcome well-retrospective analysis of clinical characteristics and management of newly-diagnosed mantle cell lymphoma patients from China.
    He JS; Chen X; Wei GQ; Sun J; Zheng WY; Shi JM; Wu WJ; Zhao Y; Zheng GF; Huang H; Cai Z
    Medicine (Baltimore); 2019 Jan; 98(1):e13741. PubMed ID: 30608386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cortactin expression in non-Hodgkin B-cell lymphomas: a new marker for the differential diagnosis between chronic lymphocytic leukemia and mantle cell lymphoma.
    Pizzi M; Trentin L; Visentin A; Saraggi D; Martini V; Guzzardo V; Righi S; Frezzato F; Piazza F; Sabattini E; Semenzato G; Rugge M
    Hum Pathol; 2019 Mar; 85():251-259. PubMed ID: 30458196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.